These results suggest that TG2-179-1 exerts its cytotoxic activity against colon cancer cells as well as other types of cancer cells, such as mesothelioma and ccRCC, by targeting BAP1. The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.